YSB (HKSE:09885) 3-Year EBITDA Growth Rate : -112.40% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is YSB 3-Year EBITDA Growth Rate?

YSB's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.05.

During the past 3 years, the average EBITDA Per Share Growth Rate was -112.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of YSB was -112.40% per year. The lowest was -112.40% per year. And the median was -112.40% per year.

Competitive Comparison of YSB's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, YSB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where YSB's 3-Year EBITDA Growth Rate falls into.

YSB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

YSB (HKSE:09885) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

YSB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of YSB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB (HKSE:09885) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines